397 related articles for article (PubMed ID: 34635950)
1. Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases.
Ling Z; Yang C; Tan J; Dou C; Chen Y
Cell Mol Life Sci; 2021 Dec; 78(23):7161-7183. PubMed ID: 34635950
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
[TBL] [Abstract][Full Text] [Related]
3. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
Rajabinejad M; Salari F; Gorgin Karaji A; Rezaiemanesh A
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4149-4158. PubMed ID: 31698956
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
5. MDSCs in bone metastasis: Mechanisms and therapeutic potential.
Li Z; Xia Q; He Y; Li L; Yin P
Cancer Lett; 2024 Jun; 592():216906. PubMed ID: 38649108
[TBL] [Abstract][Full Text] [Related]
6. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.
Suszczyk D; Skiba W; Jakubowicz-Gil J; Kotarski J; Wertel I
Cells; 2021 Mar; 10(3):. PubMed ID: 33803806
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation.
Yang Y; Li C; Liu T; Dai X; Bazhin AV
Front Immunol; 2020; 11():1371. PubMed ID: 32793192
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis.
Sawant A; Ponnazhagan S
Cancer Res; 2013 Aug; 73(15):4606-10. PubMed ID: 23887974
[TBL] [Abstract][Full Text] [Related]
9. The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis.
Yan L; Liang M; Yang T; Ji J; Jose Kumar Sreena GS; Hou X; Cao M; Feng Z
Front Immunol; 2020; 11():568362. PubMed ID: 33042149
[TBL] [Abstract][Full Text] [Related]
10. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis.
Chen S; Guo C; Wang R; Feng Z; Liu Z; Wu L; Zhao D; Zheng S; Chen F; Zhang D; Xu J; Zhu J; Chen X; Li Z; Wise CM; Li J; Wang XY
Rheumatology (Oxford); 2021 May; 60(5):2409-2420. PubMed ID: 33246326
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology of myeloid-derived suppressor cells in cancer.
Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
Wilkerson A; Kim J; Huang AY; Zhang M
Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
[TBL] [Abstract][Full Text] [Related]
13. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
Front Immunol; 2018; 9():2849. PubMed ID: 30564242
[TBL] [Abstract][Full Text] [Related]
14. [The role of myeloid-derived suppressor cells in glioma microenvironment].
Gao C; Wang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Jun; 36(3):515-520. PubMed ID: 31232558
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer.
Li K; Shi H; Zhang B; Ou X; Ma Q; Chen Y; Shu P; Li D; Wang Y
Signal Transduct Target Ther; 2021 Oct; 6(1):362. PubMed ID: 34620838
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes.
Han D; Tao J; Fu R; Shao Z
Innate Immun; 2020 Nov; 26(8):703-715. PubMed ID: 33050756
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
19. Molecular Regulation of Bone Metastasis Pathogenesis.
Wu MY; Li CJ; Yiang GT; Cheng YL; Tsai AP; Hou YT; Ho YC; Hou MF; Chu PY
Cell Physiol Biochem; 2018; 46(4):1423-1438. PubMed ID: 29689559
[TBL] [Abstract][Full Text] [Related]
20. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
